Rianne J. Hendriks
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men.
Journal: Prostate cancer and prostatic diseases
Published: November 19, 2020
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Journal: European urology
Published: August 07, 2018
Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.
Journal: The Prostate
Published: November 16, 2017
Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model.
Journal: BJU international
Published: April 04, 2017
Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
Journal: Prostate cancer and prostatic diseases
Published: August 08, 2016
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide.
Journal: Clinical pharmacokinetics
Published: April 24, 2016
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Journal: European urology
Published: October 22, 2015
Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.
Journal: Clinical chemistry and laboratory medicine
Published: June 25, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026